Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene - Phylogenetic and functional relationship with blood coagulation factor XII, urokinase, and tissue-type plasminogen activator

被引:28
|
作者
Miyazawa, K [1 ]
Wang, YM
Minoshima, S
Shimizu, N
Kitamura, N
机构
[1] Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 226, Japan
[2] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1998年 / 258卷 / 02期
关键词
hepatocyte growth factor activator; blood coagulation factor XII; gene duplication; genomic organization; chromosomal localization;
D O I
10.1046/j.1432-1327.1998.2580355.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The organization and structure of the gene coding for hepatocyte growth factor activator (HGFA) have been determined by isolation of unique clones from a human genomic library. These clones were characterized by restriction mapping, Southern blotting and DNA sequencing. The complete sequence of the gene was determined and found to span about 7.5 kilobases of DNA and consist of 14 exons separated by 13 introns. The coding region of HGFA consists of multiple putative domains that are homologous to those observed in blood coagulation factor XII (FXII). These regions were found as separate exons in the gene, and the exon/intron arrangement was similar to that of FXII, suggesting that the genes for HGFA and FXII have arisen through gene duplication events from a common ancestral gene. The major transcription initiation site is located 75 bp upstream of the translational start codon. The gene was mapped to chromosome 4p16, using spot-blot hybridization on sorted chromosomes and fluorescence in situ hybridization on metaphase chromosome spreads. The phylogenetic and functional relationships between HGFA and FXII as well as urokinase and tissue-type plasminogen activator are discussed.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 50 条
  • [21] Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation
    Riehle, Kimberly J.
    Johnson, Melissa M.
    Johansson, Fredrik
    Bauer, Renay L.
    Hayes, Brian J.
    Gilbertson, Debra G.
    Haran, Aaron C.
    Fausto, Nelson
    Campbell, Jean S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (02): : 318 - 325
  • [22] Expression of hepatocyte growth factor scatter factor, its receptor, c-met, and tissue-type plasminogen activator during development of the murine olfactory system
    Thewke, DP
    Seeds, NW
    JOURNAL OF NEUROSCIENCE, 1996, 16 (21): : 6933 - 6944
  • [23] Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes
    Lin, Y
    Xie, WF
    Chen, YX
    Zhang, X
    Zeng, X
    Qiang, H
    Chen, WZ
    Yang, XJ
    Han, ZG
    Zhang, ZB
    LIVER INTERNATIONAL, 2005, 25 (04) : 796 - 807
  • [24] IDENTIFICATION OF A SPECIFIC INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND UROKINASE IN HUMAN-BLOOD
    JUHANVAGUE, I
    MOERMAN, B
    DECOCK, F
    AILLAUD, MF
    PHILIPJOET, C
    SERRADIMIGNI, A
    COLLEN, D
    HAEMOSTASIS, 1984, 14 (01) : 40 - 40
  • [25] TRANSCRIPTIONAL REGULATION OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE BY THROMBIN IN HUMAN FETAL LUNG FIBROBLASTS
    SAKURAGAWA, N
    HAYAKAWA, Y
    ISHIKAWA, T
    NIIVA, K
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1418 - 1418
  • [26] Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells
    Takuzou Moriyama
    Hiroaki Kataoka
    Ryouichi Hamasuna
    Etsuo Yoshida
    Tetsuro Sameshima
    Tsutomu Iseda
    Kiyotaka Yokogami
    Shinichi Nakano
    Masashi Koono
    Shinichiro Wakisaka
    Clinical & Experimental Metastasis, 1999, 17 : 873 - 879
  • [27] Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells
    Moriyama, T
    Kataoka, H
    Hamasuna, R
    Yoshida, E
    Sameshima, T
    Iseda, T
    Yokogami, K
    Nakano, S
    Koono, M
    Wakisaka, S
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (10) : 873 - 879
  • [28] Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta
    Kataoka, H
    Meng, JY
    Itoh, H
    Hamasuna, R
    Shimomura, T
    Suganuma, T
    Koono, M
    HISTOCHEMISTRY AND CELL BIOLOGY, 2000, 114 (06) : 469 - 475
  • [29] Localization of hepatocyte growth factor activator inhibitor type 1 in langhans' cells of human placenta
    Kataoka H.
    Meng J.-Y.
    Itoh H.
    Hamasuna R.
    Shimomura T.
    Suganuma T.
    Koono M.
    Histochemistry and Cell Biology, 2000, 114 (6) : 469 - 475
  • [30] GROWTH FACTOR-LIKE EFFECT OF UROKINASE TYPE PLASMINOGEN-ACTIVATOR IN HUMAN RENAL-CELLS
    HE, CJ
    REBIBOU, JM
    PERALDI, MN
    MEULDERS, Q
    RONDEAU, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) : 1408 - 1416